home / stock / hcm / hcm news


HCM News and Press, HUTCHMED (China) Limited From 06/27/22

Stock Information

Company Name: HUTCHMED (China) Limited
Stock Symbol: HCM
Market: NASDAQ
Website: hutch-med.com

Menu

HCM HCM Quote HCM Short HCM News HCM Articles HCM Message Board
Get HCM Alerts

News, Short Squeeze, Breakout and More Instantly...

HCM - Epizyme stock soars 60% as Ipsen set to acquire the cancer drugmaker

France's Ipsen (OTCPK:IPSEY) (OTCPK:IPSEF) is acquiring Cambridge, Mass.-based cancer drug maker Epizyme (NASDAQ:EPZM) for $247M plus contingent value right (CVR). Ipsen will begin an all-cash tender offer to acquire all outstanding shares of Epizyme (EPZM) for $1.45/share plus a CV...

HCM - HUTCHMED to Announce 2022 Half-Year Financial Results

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 27, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its interim results for the six months ended June 30, 2022 on Monday, August 1, 2022 at 7:00 am Eas...

HCM - TAL Education, Mercury Fintech added to list of companies facing possible delisting by SEC

TAL Education Group (NYSE:TAL) and Mercury Fintech (NASDAQ:MFH) were added to a list of companies that face possible delisting from U.S. exchanges,  the Securities and Exchange Commission said on Friday. The two companies were added to the Holding Foreign Companies Accountable Act, or HF...

HCM - Bluejay, DBV top healthcare gainers; Precision, Blueprint among losers' pack

Gainers: Bluejay Diagnostics BJDX +29%. DBV Technologies DBVT +12%. Arcellx (ACLX) +10%. Immix Biopharma (IMMX) +10%. AbCellera Biologics (ABCL) +8%. Losers: Precision BioSciences (DTIL) -10%. Blueprint Medicines (BPMC) -9%. Hutchmed (China) (HCM)&...

HCM - TIGR, GOTU and DTIL among pre market gainers

Cyren (CYRN) +39% on €10M sale of secure email gateway unit. Redbox Entertainment (RDBX) +25%. DBV Technologies (DBVT) +19% phase 3 trial for peanut allergy treatment in toddlers meets main goal. Brenmiller Energy (BNRG) +16%. Energy Focus (EFOI) +15%. Aldeyra Thera...

HCM - Hutchmed, Epizyme cancer drug Tazverik gets China's Hainan province health regulator nod

Hutchmed (China) Epizyme's (NASDAQ:EPZM) cancer drug Tazverik (tazemetostat) was approved by the Health Commission and Medical Products Administration of Hainan Province. Tazverik can now be used in the Hainan Boao Lecheng International Medical Tourism Pilot Zone, under the Clinically Ur...

HCM - HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that TAZVERIK ® (tazemetostat) has been approved by the Health Commission and ...

HCM - KWEB: Already Bottomed In March - Don't Wait

The KWEB ETF has been battered significantly as investors left Chinese Internet stocks in a hurry since 2021. However, we could be in the late stage of the current malaise. Our price action analysis suggests that the worst in Chinese Internet stocks seems to have been priced in. KWEB'...

HCM - XPEV, IQ and GRAB among pre market gainers

Siyata Mobile (SYTA) +15%. Covetrus (CVET) +14%. Palo Alto Networks (PANW) +12% on Q3 results. HUTCHMED (HCM) +11%. Team (TISI) +5%. Sono Group (SEV) +8%. Faraday Future Intelligent Electric (FFIE) +7%. NIO (NIO) +7% listed on the Main Board of the Singapore Exchange. iQIY...

HCM - Appointment of Non-Executive Director

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) announces that Mr Lefei Sun has been appointed as a Non-Executive Director with effect from May 16, 2022 and he...

Previous 10 Next 10